Funded Clinical Trials

Explore Our Trials

Gateway for Cancer Research is one of the only nonprofits that exclusively funds innovative Phase I and Phase II cancer clinical trials for patients of all ages, regardless of cancer type. At the forefront of research and discovery, these early-phase trials are the first step in evaluating new cancer drugs, treatments, and therapies.

Results 11-20 of 46

Solid Tumors

Exercise Therapy as Preoperative Treatment for Solid Tumors (PRESTO)

Exercise Therapy as Preoperative Treatment for Solid Tumors (PRESTO) More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT03813615 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials

Lee Jones, PhD

Memorial Sloan Kettering Cancer Center

Solid Tumors

EphA2 Gene Targeting using Neutral Liposomal Small Interfering RNA Delivery

EphA2 Gene Targeting using Neutral Liposomal Small Interfering RNA Delivery More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT01591356 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials

Aung Naing, MD

MD Anderson Cancer Center

Lung Cancer

Phase 2 trial of the fatty acid synthase (FASN) inhibitor TVB-2640 for advanced KRAS mutant non-small cell lung cancer (NSCLC)

Phase 2 trial of the fatty acid synthase (FASN) inhibitor TVB-2640 for advanced KRAS mutant non-small cell lung cancer (NSCLC) More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT03808558 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute […]

David Gerber, MD

University of Texas Southwestern Medical Center

Brain Cancer

Pharmacological ascorbate combined with radiation and temozolomide in GBM

Pharmacological ascorbate combined with radiation and temozolomide in GBM More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT042344355 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials

Bryan Allen, MD, PhD

University of Iowa

Brain Cancer

A Phase 1 Study of M032 (NSC 733972), a Genetically Engineered HSV-1 Expressing IL- 12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma

A Phase 1 Study of M032 (NSC 733972), a Genetically Engineered HSV-1 Expressing IL- 12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT03657576 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More […]

James Markert, MD, MPH

University of Alabama at Birmingham

Cervical Cancer

Development of an LMIC-adapted Thermoablation Prototype and Treatment Protocol for Cervical Pre-Cancer

Development of an LMIC-adapted Thermoablation Prototype and Treatment Protocol for Cervical Pre-Cancer More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT03429582 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials

Miriam Cremer, MD, MPH

Cleveland Clinic Foundation

Pan Cancer

Mitochondrial-Targeted Gamitrinib for Cancer Therapy

Mitochondrial-Targeted Gamitrinib for Cancer Therapy More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT04827810 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials

Dario Altieri, MD

The Wistar Institute

Gynecologic Cancer

Targeting adaptive changes following anti-angiogenesis therapy in ovarian cancer

Targeting adaptive changes following anti-angiogenesis therapy in ovarian cancer More information to come.  Trial Registration: ClinicalTrials.gov Identifier: NCT02923739 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials

Shannon Westin, MD, MPH, FACOG

MD Anderson Cancer Center

Prostate Cancer

Impact of Cytoreductive Radical Prostatectomy on Oncologic and Quality of Life Outcome in Men with Newly Diagnosed Metastatic Prostate Cancer

Impact of Cytoreductive Radical Prostatectomy on Oncologic and Quality of Life Outcome in Men with Newly Diagnosed Metastatic Prostate Cancer More information to come. Trial Registrations: ClinicalTrials.gov Identifier: NCT03456843 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute […]

Isacc Kim, MD, PhD, MBA

Yale University

Gastrointestinal Cancer

Perioperative tadalafil and influenza vaccination in cancer patients undergoing major surgical resection of a primary abdominal malignancy

Perioperative tadalafil and influenza vaccination in cancer patients undergoing major surgical resection of a primary abdominal malignancy More information to come   Trial Registration: ClinicalTrials.gov Identifier: NCT02998736  For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read […]

Rebecca Auer, MD, MSc

Ottawa Hospital Research Institute, Canada